Science and Technology Innovation Program
The Synthetic Biology Project aims to foster informed public and policy discourse concerning the advancement of synthetic biology – an emerging interdisciplinary field that uses advanced science and engineering to make or re-design living organisms, such as bacteria, so they can carry out specific functions. Synthetic biology involves making new genetic code, also known as DNA, which does not already exist in nature. The project provides independent, rigorous analysis that can inform critical decisions affecting the research, commercialization and use of synthetic biology. Its objective is to help ensure that, as synthetic biology moves forward, possible risks are minimized and benefits maximized. For more information, please visit: http://www.synbioproject.org.
The CommonsLab is proud to announce the release of a report by Ed Robson evaluating liability issues in social media and crowdsourcing.
“Citizen Science” projects include a wide range of activities from the simple to the sophisticated. In this Context interview, Erin Heaney discusses a case in Western New York that proves the practice can have a significant impact on the health and well-being of communities.
A new report released today, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? by Michael Taylor, a former Deputy Commissioner for Policy at the Food and Drug Administration (FDA), examines the agency's capacity to properly regulate new products containing nanotechnology materials—including food, drugs, medical devices, dietary supplements and cosmetics.
In a world increasingly driven by scientific and technological breakthroughs, are we getting the information we need to understand the rapid changes and choices we face? And as print space dedicated to science decreases, have online sources emerged to fill the void?